PM
Prosight Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.67M | Buy |
479,400
+119,400
| +33% | +$1.91M | 1.87% | 18 |
|
|
2025
Q1 | $6.15M | Buy |
360,000
+54,477
| +18% | +$931K | 2.02% | 21 |
|
|
2024
Q4 | $7.57M | Sell |
305,523
-64,477
| -17% | -$1.6M | 2.09% | 19 |
|
|
2024
Q3 | $10.5M | Buy |
370,000
+45,000
| +14% | +$1.28M | 2.6% | 17 |
|
|
2024
Q2 | $8.58M | Buy |
325,000
+130,000
| +67% | +$3.43M | 2.56% | 14 |
|
|
2024
Q1 | $6.3M | Buy |
+195,000
| New | +$6.3M | 1.75% | 17 |
|
|
2020
Q3 | – | Sell |
-95,500
| Closed | -$2.33M | – | 48 |
|
|
2020
Q2 | $2.33M | Sell |
95,500
-25,929
| -21% | -$631K | 1% | 27 |
|
|
2020
Q1 | $1.89M | Sell |
121,429
-103,273
| -46% | -$1.61M | 0.88% | 29 |
|
|
2019
Q4 | $3.57M | Buy |
+224,702
| New | +$3.57M | 1.57% | 19 |
|